← Back

Zhejiang Shouxiangu Pharm Co

14.82-27.5%1Y · CNY

Zhejiang Shouxiangu Pharmaceutical Co., Ltd., along with its subsidiaries, breeds, cultivates, processes, and sells Chinese medicinal herbs in China and internationally. Under the Shouxiangu brand, it offers ganoderma lucidum spore powder, dendrobium officinale, and saffron products, as well as health and ordinary food, agricultural and sideline products, personal and skincare items, and traditional Chinese medicines. The company also engages in wholesale and retail, technology research and development, and real estate. Founded in 1909, it is headquartered in Jinhua, China.

Price · split & dividend adjusted
News & notes moving 603896.CG
China
603896.CG▲

Shouxiangu and Partners Jointly Establish Cell and Gene Venture Capital Partnership

Shouxiangu and partners have jointly funded the establishment of Hangzhou Huarui Cell and Gene Venture Capital Partnership, a limited partnership, which was recently incorporated. According to Qichacha APP, the partnership's business scope includes venture capital investment, limited to investing in unlisted companies, as well as equity investment. Qichacha equity penetration shows that the enterprise is jointly funded by Shouxiangu and others.
Zhejiang Shoux… ▲
603896.CG · Capital · Positive Shouxiangu jointly funded and established Hangzhou Huarui Cell and Gene Venture Capital Partnership, a venture capital investment vehicle.
Read original ↗
证券时报·8dRead more →
603896.CG▼2

Shouxiangu's 2026 interim report shows net profit down 43.76%

Shouxiangu released its 2026 interim report. Total operating revenue was 276 million yuan, down 7.89% year on year. Net profit attributable to the parent company was 36.8708 million yuan, down 43.76% from the same period last year. Net cash flow from operating activities was negative 35.2611 million yuan, down 128.67% year on year. Gross margin was 76.79%, down 4.02 percentage points from a year earlier. Return on equity was 1.61%, down 1.22 percentage points. Diluted earnings per share were 0.19 yuan, down 42.42% year on year.
Zhejiang Shoux… ▼
603896.CG · Capital · Negative Net profit down 43.76%, revenue down, operating cash flow negative, margins and ROE declined.
Read original ↗
Jiemian·41dRead more →
© 2026 MarketDXAsset